37 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands fora-Synuclein Fibrils.

Washington University
Synthesis and in vitro evaluation ofa-synuclein ligands.

Washington University
In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole.

Zhengzhou University
The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers.

Zhengzhou University
Therapeutic potential of Coumarin-polyphenolic acid hybrids in PD: Inhibition of α-Syn aggregation and disaggregation of preformed fibrils, leading to reduced neuronal inclusion formation.

Zhengzhou University
Novel 4-triazole phenyl amide (4-TPA) molecules: Potent promoters of α-synuclein fibril disassembly.

Fudan University
Comprehensive and critical view on the anti-inflammatory and immunomodulatory role of natural phenolic antioxidants.

University of Agronomic Sciences and Veterinary Medicine of Bucharest
Recent Advances on Small-Molecule Inhibitors of Lipocalin-like Proteins.

Sichuan University
Discovery of Effective Dual PROTAC Degraders for Neurodegenerative Disease-Associated Aggregates.

Sun Yat-sen University
Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity.

German University in Cairo
Pyrazolamide derivatives inhibit α-Synuclein aggregation, disaggregate preformed fibers, and reduce inclusion formation in neuron cells.

Zhengzhou University
Structure-Activity Relationships of Cyano-substituted Indole Derivatives as Ligands for α-Synuclein Aggregates.

Beijing Normal University
Hybrids of polyphenolic/quinone acids, the potential preventive and therapeutic drugs for PD: Disaggregate α-Syn fibrils, inhibit inclusions, and repair damaged neurons in mice.

Zhengzhou University
Discovery of Small-Molecule Degraders for Alpha-Synuclein Aggregates.

Sun Yat-Sen University
Bis-chalcone polyphenols with potential preventive and therapeutic effects on PD: Design, synthesis and in vitro disaggregation activity against α-synuclein oligomers and fibrils.

Zhengzhou University
4-Arylidene curcumin derivatives in vitro inhibit α-Synuclein aggregation and disaggregate the preformed fibril.

Zhengzhou University
Targeted Degradation of Alpha-Synuclein by Autophagosome-Anchoring Chimera Peptides.

Sun Yat-Sen University
Small molecule-based fluorescent probes for the detection of α-Synuclein aggregation states.

Csir-Indian Institute of Chemical Technology (CSIR-IICT)
Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators.

IQM-CSIC
Bioactive Aurones, Indanones, and Other Hemiindigoid Scaffolds: Medicinal Chemistry and Photopharmacology Perspectives.

Universite Grenoble Alpes
Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects.

German University In Cairo
Hybrids of polyphenolic acids and xanthone, the potential preventive and therapeutic effects on PD: Design, synthesis, in vitro anti-aggregation of α-synuclein, and disaggregation against the existed α-synuclein oligomer and fibril.

Zhengzhou University
Discovery of styrylaniline derivatives as novel alpha-synuclein aggregates ligands.

Fudan University
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation.

University of Catania
Design, synthesis and identification of N, N-dibenzylcinnamamide (DBC) derivatives as novel ligands for α-synuclein fibrils by SPR evaluation system.

Fudan University
Amide derivatives of Gallic acid: Design, synthesis and evaluation of inhibitory activities against in vitro α-synuclein aggregation.

Zhengzhou University
Anti-oligomerization sheet molecules: Design, synthesis and evaluation of inhibitory activities against α-synuclein aggregation.

Zhengzhou University
Novel Bis-heteroaryl Derivatives To Modulate Protein Aggregation for the Treatment of Neurodegenerative Diseases.

Drexel University
A routinely used protein staining dye acts as an inhibitor of wild type and mutant alpha-synuclein aggregation and modulator of neurotoxicity.

National Institute of Immunology
NOVEL DIOXANE DERIVATIVES

Boehringer Ingelheim International
Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases

Regents of The University of Colorado, A Body Corporate
Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Galapagos
USP30 inhibitors

Mitobridge
Imidazo isoindole derivative, preparation method therefor and medical use thereof

Jiangsu Hengrui Medicine
PSMA imaging agents

Siemens Medical Solutions Usa
Dipeptidyl-quinolone derivatives inhibit hypoxia inducible factor-1a prolyl hydroxylases-1, -2, and -3 with altered selectivity.

Amgen
Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.

University of Rochester